Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05928884 · ClinicalTrials.gov registry record
Ultrasound Imaging for Myofascial Pain
A clinical trial of Chronic Low Back Pain and Myofascial Pain, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 124
- Enrollment target
- 1
- Study location
NCT05928884: Completed study of Chronic Low Back Pain and Myofascial Pain, sponsored by University of Pittsburgh.
NCT05928884 is a study of Chronic Low Back Pain and Myofascial Pain that has completed, run by University of Pittsburgh. The registered enrollment target is 124 participants, below the 590-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05928884, a study of Chronic Low Back Pain and Myofascial Pain, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 124 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to develop and validate a biomarker for lumbar myofascial pain (MP) based on ultrasound obtained measurements of the lumbar muscles and fascia. The investigators will use advanced machine learning approaches and validation in a randomized controlled trial. The main questions it aims to answer are: * Will the deep learning-based marker reliably identify subjects from the 4 different groups: healthy, MP without trigger points, MP with latent trigger points, and MP with active trigger points? * Will the deep learning-based marker accurately classify/predict the severity of MP in subjects with cLBP? Participants in the healthy group will be asked to do the following tasks: * Consent/Enrollment * Measure Height/Weight * Complete Questionnaires on REDCap * Participate in Ultrasound Imaging Experiment Sessions Participants in the chronic low back pain group will be asked to do the following tasks: * Consent/Enrollment * Complete Questionnaires on REDCap * Measure Height/Weight * Undergo a Standardized Clinical Exam * Participate in Ultrasound Imaging Experiment Sessions
Primary Outcome
Participants to be diagnosed as normal, MP without TPs, MP with latent TPs, and MP with active TPs as determined by standardized clinical examinations.
Conditions Studied
Interventions
- OTHER There is no intervention. It is a phenotyping study only
Study Locations (1)
Pennsylvania
- Kauffman Medical Building - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2023-10-01 |
| Est. Completion | 2025-07-31 |
What the finished NCT05928884 record still lists
NCT05928884 is an observational study that tracks outcomes without assigning an intervention. The registered 124 participants enrollment target is mid-sized for trials with a published cap, below the 590-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (79% lower).
The record links to 2 conditions, with Chronic Low Back Pain appearing as the primary indexed condition, and to 1 intervention - of which There is no intervention. It is a phenotyping study only is the first listed.
NCT05928884 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05928884 about?
NCT05928884 is a clinical study titled "Ultrasound Imaging for Myofascial Pain". The goal of this observational study is to develop and validate a biomarker for lumbar myofascial pain (MP) based on ultrasound obtained measurements of the lumbar muscles and fascia. The investigators will use advanced machine learning approaches and validation in a randomized controlled trial. The...
What is the current status of trial NCT05928884?
This trial is currently completed. The enrollment target is 124 participants. The study started on 2023-10-01. Estimated completion is 2025-07-31.
What conditions does trial NCT05928884 study?
This clinical trial studies the following conditions: Chronic Low Back Pain, Myofascial Pain.
What interventions are being tested in trial NCT05928884?
The interventions under investigation include: There is no intervention. It is a phenotyping study only (OTHER).
Who is sponsoring clinical trial NCT05928884?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05928884 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05928884's enrollment target sits among peer trials
124 29th of 71 higher than 43 of 71 other Chronic Low Back Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mobile Neurofeedback for Low Back Pain
RECRUITING · NA
-
Phenotyping Response to Spinal Cord Stimulation in Chronic Low Back Pain
RECRUITING · NA
-
Active Music-Based Intervention in Patients With Chronic Low Back Pain
RECRUITING · NA
-
PRECISION Pain Research Registry
RECRUITING
-
Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response
RECRUITING · NA
-
Meditation for Older Adults With Chronic Low Back Pain
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523014 · 124 participants · Phase 2
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- NCT02670707 · 124 participants · Phase 3
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- NCT02830724 · 124 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- NCT04748809 · 124 participants · NA
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI